Wellcome Sanger Institute Best Practice - the Nagoya Protocol and Access and Benefit Sharing (ABS) | ABSCH-A19A20-SCBD-262671 | Типовые договорные положения, кодексы поведения, руководящие указания и передовые методы и/или стандарт | Access and Benefit-Sharing Clearing-HouseAccess and Benefit-Sharing Clearing-HouseAccess and Benefit-Sharing Clearing-House/ru/
Срок действия сеанса истек. Срок действия сеанса истек. Выполните вход для продолжения.
Ошибка входа. Введен неверный адрес электронной почты или пароль.
Сбой операции. Служба недоступна. Повторите попытку позже.
This document has been produced in order to provide assurance to Nagoya Protocol member states, regulators, researchers, collaborators and peers, that the Wellcome Sanger Institute has initiated and carries out appropriate processes and procedures to enable compliance with global Access and Benefit Sharing (hereafter; ABS) measures and compliance with the UK ABS legislation5 implementing the Nagoya Protocol1 for scientific research undertaken. Within this document are the tools, processes and procedures, comprising Institute policy, that when employed correctly staff and associates of the Wellcome Sanger Institute can be confident that they are conducting their research in accordance with the UK ABS legislation and in turn, ABS legislation in force globally.